Skip to content

The influence of surgical trauma and early postoperative inflammatory response on acute pain following primary total hip and knee arthroplasty

The influence of surgical trauma and early postoperative inflammatory response on acute pain following primary total hip and knee arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RCH-14004862
Enrollment
Unknown
Registered
2014-04-27
Start date
2014-07-07
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end-stage hip and knee joint non-inflammatory disease

Interventions

TKA group:total knee joint arthroplasty
THA group:total hip joint arthroplasty

Sponsors

West China hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years old, normal consciousness, can understand the purpose and score of this study and sign the informed consent, not take NSAIDS, COX-2 specific inhibitor and hormone at least 2 weeks before admission; 2. A diagnosis of non infectious arthritis of hip or knee(hip: osteoarthritis, avascular necrosis of the femoral head, developmental dysplasia of the hip; knee: osteoarthritis); 3. Preoperative blood ESR, C reactive protein were normal; 4. No allergic to the COX-2 specific inhibitor, sulfonamides, NSAIDS, opioid or paracetamol / acetaminophen; 5. Accept primary, unilateral, elective total hip or knee arthroplasty in our hospital and the operation was performed by the same senior joint surgeon.

Exclusion criteria

Exclusion criteria: 1. Younger than 18 years or older than 75 years old, psychiatric or neurological or mental drugs was used currently; 2. Septic arthritis, joint arthroplasty following fracture, emergency operation, bilateral arthroplasty and revision operation, etc.; 3. Preoperative blood ESR, C reactive protein was higher than the reference value; 4. Allergic to the COX-2 specific inhibitor, sulfonamides, NSAIDS, opioid or paracetamol / acetaminophen; 5. Without control of chronic disease, clinical disease, or the researchers estimate that it may hinder the execution or affect the results of the study.

Design outcomes

Primary

MeasureTime frame
pain score;ESR;CRP;IL-1 beta;IL-6;PCT;LDH;AST;TNF alpha;CK;myoglobin;hip and knee function evaluation;local skin temperature;

Countries

China

Contacts

Public ContactShen Bin

West China hospital, Sichuan University

shenbin_1971@163.com+86 13881878767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026